BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($29.53 B vs $13.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXEL | BIIB |
|---|---|---|
| Market cap | $13.35 B | $29.53 B |
| US-listed rank | #792 | #476 |
| Revenue (latest FY) | $2.32B | $9.89B |
| Net income (latest FY) | $782.60M | $1.29B |
| Net margin | 33.7% | 13.1% |
| P/E (trailing FY) | 17.1 | 22.8 |
| SEC filings | 2,488 | 2,690 |
BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($29.53 B vs $13.35 B).
In their latest fiscal years, EXELIXIS, INC. reported $2.32B in revenue while BIOGEN INC. reported $9.89B.
Full pages: EXELIXIS, INC. and BIOGEN INC., or browse the full rankings.